Cagrilintide is a long-acting amylin analog studied for its potential role in appetite regulation and metabolic control. It mimics the activity of amylin, a hormone co-secreted with insulin that helps regulate satiety, gastric emptying, and postprandial glucose levels.

Cagrilintide is believed to act on central appetite pathways in the brain, promoting a prolonged feeling of fullness and reduced caloric intake. It is commonly researched for its possible effects on weight management, energy balance, and metabolic health, particularly in combination strategies targeting multiple hormonal pathways involved in obesity and glycemic regulation.